Close

Vifor Pharma, ChemoCentryx (CCXI) Expand Pact to Include CCX140 to Treat Renal Diseases

December 22, 2016 12:31 PM EST Send to a Friend
Vifor Pharma, a company of the Galenica Group, and ChemoCentryx, Inc., (Nasdaq: CCXI), announced today the expansion of their existing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login